Royalty Pharma Sub-Manager, LLC - Portfolio overview

Royalty Pharma Sub-Manager, LLC has 4 reported holdings in this dataset, with the latest filing dated 2026-05-14.

Its largest classified asset exposures are stocks.

Its largest classified sector exposures are Healthcare.

Largest reported holdings by portfolio allocation

1. CYTK - CYTOKINETICS, INC, 37.40%
2. BCAX - ZENAS BIOPHARMA, INC., 27.02%
3. BCRX - BIOCRYST PHARMACEUTICALS INC, 21.19%

These figures describe reported SEC 13F holdings, which may not represent the institution's entire portfolio or current positions.

Explore securities or join Upside Invest to compare portfolios.